These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 11107682)
1. [Ramipril and new therapeutic possibilities for ACE-inhibitors]. Vespasiani Gentilucci U; Picardi A Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682 [No Abstract] [Full Text] [Related]
2. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. Gerstein HC Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991 [TBL] [Abstract][Full Text] [Related]
3. Diabetes and the HOPE study: implications for macrovascular and microvascular disease. Gerstein HC Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357 [TBL] [Abstract][Full Text] [Related]
4. ACE inhibitors and antihypertensive treatment in diabetes: focus on microalbuminuria and macrovascular disease. Mogensen CE J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):234-9. PubMed ID: 11881030 [No Abstract] [Full Text] [Related]
5. [ACE inhibitors for diabetic patients. passed the test on the heart and kidneys]. MMW Fortschr Med; 2002 Oct; 144(44):53. PubMed ID: 12494601 [No Abstract] [Full Text] [Related]
6. HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation. Marshall SM Diabet Med; 2000 Sep; 17 Suppl 2():9-10. PubMed ID: 11048826 [No Abstract] [Full Text] [Related]
7. [Experiences with the realisation of the innovative study designs using the example of the HOPE study -- concerning the contribution in DMW Supplement 2/2005]. Traut V Dtsch Med Wochenschr; 2005 Nov; 130(47):2726; author reply 2727-8. PubMed ID: 16294292 [No Abstract] [Full Text] [Related]
8. [Symposium "Emerging Approaches to Cardiovascular Diseases: Detailed results and implications of the HOPE Study". Atlanta, 10. November 1999]. Bischoff A Internist (Berl); 2000 Jan; 41(1):A24-7. PubMed ID: 10712083 [No Abstract] [Full Text] [Related]
9. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers]. Costantino S; Millozzi F; Scarlata S Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526 [No Abstract] [Full Text] [Related]
10. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors. Crook ED; Preddie DC Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155 [TBL] [Abstract][Full Text] [Related]
14. [Vascular patient with high infarction risk. Does the AT-1 blocker protect as well as an ACE inhibitor?]. MMW Fortschr Med; 2003 Dec; 145(51-52):39. PubMed ID: 14974331 [No Abstract] [Full Text] [Related]
16. Improving microvascular outcomes in patients with diabetes through management of hypertension. McGill JB Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966 [TBL] [Abstract][Full Text] [Related]
17. The renin angiotensin system and cardiovascular disease: hope or hype? Williams B J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):142-6. PubMed ID: 11967805 [No Abstract] [Full Text] [Related]
18. The HOPE Study (Heart Outcomes Prevention Evaluation). Sleight P J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789 [TBL] [Abstract][Full Text] [Related]
19. Preventing stroke with ramipril. Presentation of data is misleading. Parmar MS BMJ; 2002 Aug; 325(7361):439. PubMed ID: 12201281 [No Abstract] [Full Text] [Related]
20. Diabetic complications and early treatment using ACE inhibitors: concluding remarks. Mogensen CE J Diabetes Complications; 1996; 10(3):151-3. PubMed ID: 8807464 [No Abstract] [Full Text] [Related] [Next] [New Search]